A therapeutic intervention for amyotrophic lateral sclerosis, better known as ALS or Lou Gehrig’s disease, could be on the horizon
Continue reading »
mypharmacynews.com
Home »
A therapeutic intervention for amyotrophic lateral sclerosis, better known as ALS or Lou Gehrig’s disease, could be on the horizon
Continue reading »Patients with ALS (amyotrophic lateral sclerosis) often suffer from type 2 diabetes. This phenomenon has long remained mechanistically enigmatic. Now,
Continue reading »Can a computer be used to explain why an environmental toxin might lead to neurodegenerative disease? According to Penn State
Continue reading »Amyotrophic lateral sclerosis (ALS) is a neurological condition that affects motor neurons—the nerve cells that control breathing and muscles. Under
Continue reading »Remember the Ice Bucket Challenge? The social media campaign that had everyone from celebrities to politicians dumping buckets of icy
Continue reading »Ben-Gurion University of the Negev (BGU) has developed a new artificial intelligence (AI) platform for monitoring and predicting progression of
Continue reading »Researchers from North Carolina State University have identified proteins that may be useful in both earlier diagnosis of Amyotrophic Lateral
Continue reading »ALS, or amyotrophic lateral sclerosis, is a neurodegenerative disease of some fame in the United States. Many Americans know the
Continue reading »Recent research from Houston Methodist Hospital showed that a new immunotherapy was safe for patients with ALS and also revealed
Continue reading »Nearly half of all patients with amyotrophic lateral sclerosis (ALS), a fatal neuromuscular disorder, develop cognitive problems that affect memory
Continue reading »